Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus.
Aged
Asymptomatic Diseases
Austria
/ epidemiology
Biomarkers
/ blood
Blood Glucose
/ metabolism
Carotid Stenosis
/ diagnostic imaging
Cause of Death
Coronary Vessels
/ diagnostic imaging
Diabetes Mellitus
/ blood
Female
Glycated Hemoglobin
/ metabolism
Humans
Male
Middle Aged
Predictive Value of Tests
Prognosis
Prospective Studies
Risk Assessment
Risk Factors
Severity of Illness Index
Time Factors
Ultrasonography, Doppler, Duplex
Biomarker
Carotid atherosclerosis
Diabetes mellitus
Hba1c
Risk factor
Journal
Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637
Informations de publication
Date de publication:
12 07 2019
12 07 2019
Historique:
received:
09
04
2019
accepted:
09
07
2019
entrez:
14
7
2019
pubmed:
14
7
2019
medline:
31
3
2020
Statut:
epublish
Résumé
Experimental and clinical data indicate a major influence of diabetes on atherogenesis. We aimed to assess whether the effect of diabetes on long-term mortality in asymptomatic patient with carotid stenosis is contingent upon the degree of the carotid atherosclerotic burden. 1065 patients with neurological asymptomatic carotid atherosclerosis as evaluated by duplex sonography were prospectively followed for cause-specific mortality. During a median of 11.8 years, a total of 549 deaths, including 362 cardiovascular deaths, were recorded. Diabetes and glycohemoglobin A1c (Hba1c) levels were significantly associated with mortality. Diabetes displayed an independent risk for all-cause (adjusted HR 1.62; 95% CI 1.35-1.94) and cardiovascular death (adjusted HR 1.75, 95% CI 1.40-2.19). The adjusted hazard ratio per increase of 1% of Hba1c levels was 1.21 (P < 0.01) for all-cause and 1.31 (P < 0.01) for cardiovascular mortality, respectively. Patients with diabetes mellitus and a higher degree of carotid stenosis and were at great risk of adverse outcome. Only 21% of the asymptomatic diabetic patients with carotid narrowing over 50% survived, whereas 62% of the patients without diabetes and with carotid atherosclerosis below 50% were still alive after 12-years of follow-up. The high risk for all-cause and cardiovascular death of these patients remained significant after adjustment for various established cardiovascular risk factors in multivariable regression analysis (adjusted hazard ratio 2.4, P < 0.001; compared to patients without diabetes and < 50% carotid atherosclerosis). Diabetic patients with carotid stenosis ≥ 50% are at exceptional high risk for all-cause and cardiovascular death. Thus, routinely ultrasound investigation of the carotid arteries might be a valuable prognostic tool for patients with diabetes mellitus.
Sections du résumé
BACKGROUND
Experimental and clinical data indicate a major influence of diabetes on atherogenesis. We aimed to assess whether the effect of diabetes on long-term mortality in asymptomatic patient with carotid stenosis is contingent upon the degree of the carotid atherosclerotic burden.
METHODS
1065 patients with neurological asymptomatic carotid atherosclerosis as evaluated by duplex sonography were prospectively followed for cause-specific mortality.
RESULTS
During a median of 11.8 years, a total of 549 deaths, including 362 cardiovascular deaths, were recorded. Diabetes and glycohemoglobin A1c (Hba1c) levels were significantly associated with mortality. Diabetes displayed an independent risk for all-cause (adjusted HR 1.62; 95% CI 1.35-1.94) and cardiovascular death (adjusted HR 1.75, 95% CI 1.40-2.19). The adjusted hazard ratio per increase of 1% of Hba1c levels was 1.21 (P < 0.01) for all-cause and 1.31 (P < 0.01) for cardiovascular mortality, respectively. Patients with diabetes mellitus and a higher degree of carotid stenosis and were at great risk of adverse outcome. Only 21% of the asymptomatic diabetic patients with carotid narrowing over 50% survived, whereas 62% of the patients without diabetes and with carotid atherosclerosis below 50% were still alive after 12-years of follow-up. The high risk for all-cause and cardiovascular death of these patients remained significant after adjustment for various established cardiovascular risk factors in multivariable regression analysis (adjusted hazard ratio 2.4, P < 0.001; compared to patients without diabetes and < 50% carotid atherosclerosis).
CONCLUSION
Diabetic patients with carotid stenosis ≥ 50% are at exceptional high risk for all-cause and cardiovascular death. Thus, routinely ultrasound investigation of the carotid arteries might be a valuable prognostic tool for patients with diabetes mellitus.
Identifiants
pubmed: 31299990
doi: 10.1186/s12933-019-0895-0
pii: 10.1186/s12933-019-0895-0
pmc: PMC6626411
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Glycated Hemoglobin A
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
90Références
Catheter Cardiovasc Interv. 2013 Jan 1;81(1):E76-123
pubmed: 23281092
Vascul Pharmacol. 2018 Oct;109:17-26
pubmed: 29879463
Cardiovasc Diabetol. 2017 Jun 6;16(1):74
pubmed: 28587650
J Am Coll Cardiol. 2019 Apr 2;73(12):1371-1382
pubmed: 30922468
Cardiovasc Diabetol. 2018 Feb 05;17(1):24
pubmed: 29402270
Cell Metab. 2018 Sep 4;28(3):337-352
pubmed: 30184484
Stroke. 2006 Jan;37(1):87-92
pubmed: 16339465
Handb Clin Neurol. 2014;126:167-74
pubmed: 25410221
Radiology. 2003 Nov;229(2):340-6
pubmed: 14500855
Circ Res. 2016 May 27;118(11):1808-29
pubmed: 27230643
J Atheroscler Thromb. 2018 Oct 1;25(10):1053-1066
pubmed: 29445076
Circulation. 1997 Sep 2;96(5):1432-7
pubmed: 9315528
Eur Heart J. 2012 Jan;33(2):183-90
pubmed: 21666250
Circulation. 2003 Oct 7;108(14):1664-72
pubmed: 14530185
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
pubmed: 17569110
Diabetes Care. 1997 Jul;20(7):1183-97
pubmed: 9203460
Cardiol Clin. 2014 Aug;32(3):439-55
pubmed: 25091969
Stroke. 1992 Dec;23(12):1705-11
pubmed: 1448818
Clin Cardiol. 2017 May;40(5):287-291
pubmed: 28026025
Cardiovasc Diabetol. 2017 Jul 28;16(1):94
pubmed: 28750634
J Am Coll Cardiol. 2012 Oct 16;60(16):1489-99
pubmed: 22999719
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
Circulation. 2005 May 3;111(17):2203-9
pubmed: 15851593
Drug Deliv. 2011 Jan;18(1):74-8
pubmed: 20854110
Atherosclerosis. 2015 Aug;241(2):533-8
pubmed: 26093886
Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123
pubmed: 30559236
Circulation. 2019 Mar 12;139(11):1384-1395
pubmed: 30586757
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Lancet Diabetes Endocrinol. 2018 Jun;6(6):435-437
pubmed: 29030201
Thromb Res. 2019 May;177:130-135
pubmed: 30897531
Diabetes Care. 2015 Oct;38(10):1921-9
pubmed: 26180107
J Cardiovasc Ultrasound. 2016 Jun;24(2):91-5
pubmed: 27358696